Poster 156 Dysport® , AbobotulinumtoxinA, Improves Disease-Specific Quality of Life in Patients with Cervical Dystonia, as Measured by Patient-Reported Outcomes, in a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
Picaut, Philippe, Pharmacy, Doctor of, PhD, Poewe, Werner, MD, Vohanka, Stanislav, MD, Ilkowski, Jan, MD, Dzyak, Ludmyla, MD, Kovacs, Tibor, MD, Belova, Anna, MD, Liu, Wenzhong J., MD
Published in PM & R (01.09.2014)
Published in PM & R (01.09.2014)
Get full text
Journal Article
Poster 155 Dysport® , AbobotulinumtoxinA, is Effective with a Favorable Safety Profile in the Treatment of Cervical Dystonia: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
Picaut, Philippe, Pharmacy, Doctor of, PhD, Poewe, Werner, MD, Bihari, Katalin, MD, Banach, Marta, MD, Bares, Martin, MD, PhD, Potulska-Chromik, Anna, MD, PhD, Ehler, Edvard, MD, Liu, Wenzhong J., MD
Published in PM & R (01.09.2014)
Published in PM & R (01.09.2014)
Get full text
Journal Article
Poster 404 Randomized, Double-Blind Placebo-Controlled Phase III Study of Dysport®, AbobotulinumtoxinA, in the Treatment of Adults with Upper Limb Spasticity
Gracies, Jean-Michel, MD, PhD, Brashear, Allison, MD, Allister, Peter Mc, MD, Walker, Heather W., MD, Marciniak, Christina M., MD, Gul, Fatma, MD, Edgley, Steven R., MD, Picaut, Philippe, Pharmacy, Doctor of, PhD
Published in PM & R (01.09.2014)
Published in PM & R (01.09.2014)
Get full text
Journal Article